Fields of science
- 305 Other Human Medicine, Health Sciences
- 304 Medical Biotechnology
- 303 Health Sciences
- 302 Clinical Medicine
- 301 Medical-Theoretical Sciences, Pharmacy
- 302024 Haematology
- 302055 Oncology
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1 (Journal or book series)
- Sonja Heibl (Editor)
- Veronika Buxhofer-Ausch (Editor)
- Stefan Schmidt (Editor)
- Gerald Webersinke (Editor)
- Thomas Lion (Editor)
- Gudrun Piringer (Editor)
- Thomas Kühr (Editor)
- Dominik Wolf (Editor)
- Thomas Melchardt (Editor)
- Richard Greil (Editor)
- Josef Thaler (Editor)
Activity: Publication peer-review and editorial work › Editorial work